# D-Ribose for Fatigue in Subjects With Fibromyalgia

> **NCT01315210** · PHASE2 · COMPLETED · sponsor: **RiboCor, Inc.** · enrollment: 110 (actual)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** D-Ribose Powder
- **DIETARY_SUPPLEMENT:** Placebo Powder

## Key facts

- **NCT ID:** NCT01315210
- **Lead sponsor:** RiboCor, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2013-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01315210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01315210, "D-Ribose for Fatigue in Subjects With Fibromyalgia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01315210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*